Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.

MLA

Kronenberger, Bernd, et al. “Efficacy of Amantadine on Quality of Life in Patients with Chronic Hepatitis C Treated with Interferon-Alpha and Ribavirin: Results from a Randomized, Placebo-Controlled, Double-Blind Trial.” European Journal of Gastroenterology & Hepatology, vol. 19, no. 8, Aug. 2007, pp. 639–46. EBSCOhost, https://doi.org/10.1097/MEG.0b013e3281ac20ca.

APA

Kronenberger, B., Berg, T., Herrmann, E., Hinrichsen, H., Gerlach, T., Buggisch, P., Spengler, U., Goeser, T., Nasser, S., Wursthorn, K., Pape, G. R., Hopf, U., & Zeuzem, S. (2007). Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. European Journal of Gastroenterology & Hepatology, 19(8), 639–646. https://doi.org/10.1097/MEG.0b013e3281ac20ca

Chicago

Kronenberger, Bernd, Thomas Berg, Eva Herrmann, Holger Hinrichsen, Tilman Gerlach, Peter Buggisch, Ulrich Spengler, et al. 2007. “Efficacy of Amantadine on Quality of Life in Patients with Chronic Hepatitis C Treated with Interferon-Alpha and Ribavirin: Results from a Randomized, Placebo-Controlled, Double-Blind Trial.” European Journal of Gastroenterology & Hepatology 19 (8): 639–46. doi:10.1097/MEG.0b013e3281ac20ca.